Follicle-Stimulating Hormone (FSH) Action on Spermatogenesis: A Focus on Physiological and Therapeutic Roles

Background: Human reproduction is regulated by the combined action of the follicle-stimulating hormone (FSH) and the luteinizing hormone (LH) on the gonads. Although FSH is largely used in female reproduction, in particular in women attending assisted reproductive techniques to stimulate multi-follicular growth, its efficacy in men with idiopathic infertility is not clearly demonstrated. Indeed, whether FSH administration improves fertility in patients with hypogonadotropic hypogonadism, the therapeutic benefit in men presenting alterations in sperm production despite normal FSH serum levels is still unclear. In the present review, we evaluate the potential pharmacological benefits of FSH administration in clinical practice. Methods: This is a narrative review, describing the FSH physiological role in spermatogenesis and its potential therapeutic action in men. Results: The FSH role on male fertility is reviewed starting from the physiological control of spermatogenesis, throughout its mechanism of action in Sertoli cells, the genetic regulation of its action on spermatogenesis, until the therapeutic options available to improve sperm production. Conclusion: FSH administration in infertile men has potential benefits, although its action should be considered by evaluating its synergic action with testosterone, and well-controlled, powerful trials are required. Prospective studies and new compounds could be developed in the near future.

[1]  D. Santi,et al.  FSH treatment of male idiopathic infertility: Time for a paradigm change , 2019, Andrology.

[2]  G. Balercia,et al.  Use of follicle‐stimulating hormone for the male partner of idiopathic infertile couples in Italy: Results from a multicentre, observational, clinical practice survey , 2019, Andrology.

[3]  A. Calogero,et al.  FSH dosage effect on conventional sperm parameters: a meta-analysis of randomized controlled studies , 2019, Asian journal of andrology.

[4]  A. Salonia,et al.  Paediatric and adult-onset male hypogonadism , 2019, Nature Reviews Disease Primers.

[5]  P. Crépieux,et al.  Molecular Mechanisms of Action of FSH , 2019, Front. Endocrinol..

[6]  Jacques Young,et al.  Clinical Management of Congenital Hypogonadotropic Hypogonadism. , 2019, Endocrine reviews.

[7]  I. Huhtaniemi,et al.  Role of Follicle-Stimulating Hormone in Spermatogenesis , 2018, Front. Endocrinol..

[8]  A. Herbison The Gonadotropin-Releasing Hormone Pulse Generator. , 2018, Endocrinology.

[9]  R. Lefkowitz,et al.  Manifold roles of β-arrestins in GPCR signaling elucidated with siRNA and CRISPR/Cas9 , 2018, Science Signaling.

[10]  Ross C. Anderson,et al.  Gonadotropins and Their Analogs: Current and Potential Clinical Applications , 2018, Endocrine reviews.

[11]  D. Goulis,et al.  European Academy of Andrology guideline Management of oligo‐astheno‐teratozoospermia , 2018, Andrology.

[12]  S. Esteves,et al.  Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis , 2018, Human reproduction update.

[13]  D. Santi,et al.  Two Hormones for One Receptor: Evolution, Biochemistry, Actions, and Pathophysiology of LH and hCG , 2018, Endocrine reviews.

[14]  D. Santi,et al.  Pharmacogenetics of G-protein-coupled receptors variants: FSH receptor and infertility treatment. , 2018, Best practice & research. Clinical endocrinology & metabolism.

[15]  B. Keevil,et al.  Constitutively active follicle-stimulating hormone receptor enables androgen-independent spermatogenesis , 2018, The Journal of clinical investigation.

[16]  M. Carini,et al.  Effectiveness of highly purified urofollitropin treatment in patients with idiopathic azoospermia before testicular sperm extraction , 2018, Urologia.

[17]  A. Lenzi,et al.  The use of follicle stimulating hormone (FSH) for the treatment of the infertile man: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS) , 2018, Journal of Endocrinological Investigation.

[18]  S. Majumdar,et al.  Hormone induced differential transcriptome analysis of Sertoli cells during postnatal maturation of rat testes , 2018, PloS one.

[19]  A. Poupon,et al.  G protein‐dependent signaling triggers a β‐arrestin‐scaffolded p70S6K/ rpS6 module that controls 5'TOP mRNA translation , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  X. Xia,et al.  The susceptibility of FSHB -211G > T and FSHR G-29A, 919A > G, 2039A > G polymorphisms to men infertility: an association study and meta-analysis , 2017, BMC Medical Genetics.

[21]  U. Kaiser,et al.  Pulsatile GnRH Therapy May Restore Hypothalamus–Pituitary–Testis Axis Function in Patients With Congenital Combined Pituitary Hormone Deficiency: A Prospective, Self-Controlled Trial , 2017, The Journal of clinical endocrinology and metabolism.

[22]  G. Guerra‐Júnior,et al.  A Novel Homozygous Missense FSHR Variant Associated with Hypergonadotropic Hypogonadism in Two Siblings from a Brazilian Family , 2017, Sexual Development.

[23]  M. Nie,et al.  Novel FSHβ mutation in a male patient with isolated FSH deficiency and infertility. , 2017, European journal of medical genetics.

[24]  R. Shankar,et al.  An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism , 2017, Reproductive Biology and Endocrinology.

[25]  M. Zacharin,et al.  Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? ‐a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence‐ , 2017, Clinical endocrinology.

[26]  U. Kaiser,et al.  Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism , 2016, Asian journal of andrology.

[27]  S. Majumdar,et al.  Advantages of pulsatile hormone treatment for assessing hormone-induced gene expression by cultured rat Sertoli cells , 2017, Cell and Tissue Research.

[28]  A. Poupon,et al.  Profiling of FSHR negative allosteric modulators on LH/CGR reveals biased antagonism with implications in steroidogenesis , 2016, Molecular and Cellular Endocrinology.

[29]  P. Stanton Regulation of the blood-testis barrier. , 2016, Seminars in cell & developmental biology.

[30]  E. Baldi,et al.  Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p.N680S: a pharmacogenetic study. , 2016, Human reproduction.

[31]  E. Nieschlag,et al.  Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults , 2016, Andrology.

[32]  H. Fan,et al.  Development and characterization of a novel long-acting recombinant follicle stimulating hormone agonist by fusing Fc to an FSH-β subunit. , 2016, Human reproduction.

[33]  Wan-long Tan,et al.  Treatment of idiopathic oligozoospermia with recombinant human follicle‐stimulating hormone: a prospective, randomized, double‐blind, placebo‐controlled clinical study in Chinese population , 2015, Clinical endocrinology.

[34]  M. Riera,et al.  FSH and bFGF regulate the expression of genes involved in Sertoli cell energetic metabolism. , 2015, General and comparative endocrinology.

[35]  I. Huhtaniemi A short evolutionary history of FSH-stimulated spermatogenesis , 2015, Hormones.

[36]  C. Cheng,et al.  The Mammalian Blood-Testis Barrier: Its Biology and Regulation. , 2015, Endocrine reviews.

[37]  M. Maghnie,et al.  Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism—pathogenesis, diagnosis and treatment , 2015, Nature Reviews Endocrinology.

[38]  Wenjie Liu,et al.  Deletion of the tyrosine phosphatase Shp2 in Sertoli cells causes infertility in mice , 2015, Scientific Reports.

[39]  D. Santi,et al.  FSH treatment of male idiopathic infertility improves pregnancy rate: a meta-analysis , 2015, Endocrine connections.

[40]  I. Huhtaniemi,et al.  A novel inactivating mutation of the LH/chorionic gonadotrophin receptor with impaired membrane trafficking leading to Leydig cell hypoplasia type 1. , 2015, European journal of endocrinology.

[41]  H. Kaessmann,et al.  Research resource: the dynamic transcriptional profile of sertoli cells during the progression of spermatogenesis. , 2015, Molecular endocrinology.

[42]  E. Mannucci,et al.  Factors affecting spermatogenesis upon gonadotropin‐replacement therapy: a meta‐analytic study , 2014, Andrology.

[43]  M. Simoni,et al.  FSHR polymorphism p.N680S mediates different responses to FSH in vitro , 2014, Molecular and Cellular Endocrinology.

[44]  A. Jablonka-Shariff,et al.  Effect of single-chain ovine gonadotropins with dual activity on ovarian function in sheep. , 2014, Reproduction.

[45]  S. Palmer,et al.  Investigation of a thiazolidinone derivative as an allosteric modulator of follicle stimulating hormone receptor: evidence for its ability to support follicular development and ovulation. , 2014, Biochemical pharmacology.

[46]  T. E. Richardson,et al.  Discovery of substituted benzamides as follicle stimulating hormone receptor allosteric modulators. , 2014, Bioorganic & medicinal chemistry letters.

[47]  M. Punab,et al.  Reproductive Physiology in Young Men Is Cumulatively Affected by FSH-Action Modulating Genetic Variants: FSHR -29G/A and c.2039 A/G, FSHB -211G/T , 2014, PloS one.

[48]  K. Naresh,et al.  Overlapping dose responses of spermatogenic and extragonadal testosterone actions jeopardize the principle of hormonal male contraception , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  M. Simoni,et al.  Mechanisms in endocrinology: Genetics of FSH action: a 2014-and-beyond view. , 2014, European journal of endocrinology.

[50]  P. Schlegel,et al.  Medical treatment of male infertility , 2014, Translational andrology and urology.

[51]  Brice Campo,et al.  Inhibition of Follicle-Stimulating Hormone‐Induced Preovulatory Follicles in Rats Treated with a Nonsteroidal Negative Allosteric Modulator of Follicle-Stimulating Hormone Receptor1 , 2014, Biology of reproduction.

[52]  B. Anawalt Approach to male infertility and induction of spermatogenesis. , 2013, The Journal of clinical endocrinology and metabolism.

[53]  G. Livera,et al.  Depletion of the p43 Mitochondrial T3 Receptor Increases Sertoli Cell Proliferation in Mice , 2013, PloS one.

[54]  B. Dofitas,et al.  Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: a meta‐analysis , 2013, Andrology.

[55]  A. Abou-Setta,et al.  Gonadotrophins for idiopathic male factor subfertility. , 2013, The Cochrane database of systematic reviews.

[56]  Jeremy A. Miller,et al.  RiboTag Analysis of Actively Translated mRNAs in Sertoli and Leydig Cells In Vivo , 2013, PloS one.

[57]  C. Timmers,et al.  Signaling of an allosteric, nanomolar potent, low molecular weight agonist for the follicle-stimulating hormone receptor. , 2013, Biochemical pharmacology.

[58]  B. Conne,et al.  An essential role for insulin and IGF1 receptors in regulating sertoli cell proliferation, testis size, and FSH action in mice. , 2013, Molecular endocrinology.

[59]  Hyung-Goo Kim,et al.  The Molecular Basis of Impaired Follicle-Stimulating Hormone Action , 2013, Reproductive Sciences.

[60]  C. Niederberger,et al.  Optimization of spermatogenesis‐regulating hormones in patients with non‐obstructive azoospermia and its impact on sperm retrieval: a multicentre study , 2013, BJU international.

[61]  M. Punab,et al.  Study in 1790 Baltic men: FSHR Asn680Ser polymorphism affects total testes volume , 2012, Andrology.

[62]  David Handelsman,et al.  Temporal role of Sertoli cell androgen receptor expression in spermatogenic development. , 2013, Molecular endocrinology.

[63]  D. D. de Rooij,et al.  Molecular control of rodent spermatogenesis. , 2012, Biochimica et biophysica acta.

[64]  G. Durand,et al.  Normal testicular function without detectable follicle-stimulating hormone. A novel mutation in the follicle-stimulating hormone receptor gene leading to apparent constitutive activity and impaired agonist-induced desensitization and internalization , 2012, Molecular and Cellular Endocrinology.

[65]  M. Simoni,et al.  LH and hCG Action on the Same Receptor Results in Quantitatively and Qualitatively Different Intracellular Signalling , 2012, PloS one.

[66]  P. Dabadghao,et al.  Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis. , 2012, Fertility and sterility.

[67]  Aleksander Giwercman,et al.  European Association of Urology guidelines on Male Infertility: the 2012 update. , 2012, European urology.

[68]  M. Punab,et al.  Combined effects of the variants FSHB -211G>T and FSHR 2039A>G on male reproductive parameters. , 2012, The Journal of clinical endocrinology and metabolism.

[69]  N. Colacurci,et al.  Recombinant human FSH reduces sperm DNA fragmentation in men with idiopathic oligoasthenoteratozoospermia. , 2012, Journal of andrology.

[70]  M. Guerquin,et al.  Thyroid Hormone Limits Postnatal Sertoli Cell Proliferation In Vivo by Activation of Its Alpha1 Isoform Receptor (TRalpha1) Present in These Cells and by Regulation of Cdk4/JunD/c-myc mRNA Levels in Mice1 , 2012, Biology of reproduction.

[71]  François Fages,et al.  Competing G protein-coupled receptor kinases balance G protein and β-arrestin signaling , 2012, Molecular systems biology.

[72]  L. Vignozzi,et al.  Emerging medication for the treatment of male hypogonadism , 2012, Expert opinion on emerging drugs.

[73]  R. Sharpe Sperm counts and fertility in men: a rocky road ahead , 2012, EMBO reports.

[74]  M. Riera,et al.  Signal transduction pathways in FSH regulation of rat Sertoli cell proliferation. , 2012, American journal of physiology. Endocrinology and metabolism.

[75]  Jacques Young,et al.  Male acquired hypogonadotropic hypogonadism: diagnosis and treatment. , 2012, Annales d'endocrinologie.

[76]  J. Morales,et al.  mRNA-selective translation induced by FSH in primary Sertoli cells. , 2012, Molecular endocrinology.

[77]  K. Shiraishi,et al.  Human chorionic gonadotrophin treatment prior to microdissection testicular sperm extraction in non-obstructive azoospermia. , 2012, Human reproduction.

[78]  Anne Poupon,et al.  Mapping the Follicle-Stimulating Hormone-Induced Signaling Networks , 2011, Front. Endocrin..

[79]  C. Foresta,et al.  The response to FSH treatment in oligozoospermic men depends on FSH receptor gene polymorphisms. , 2011, International journal of andrology.

[80]  S. Mahale,et al.  Follicle-stimulating hormone receptor polymorphism (G-29A) is associated with altered level of receptor expression in Granulosa cells. , 2011, The Journal of clinical endocrinology and metabolism.

[81]  Brice Campo,et al.  A negative allosteric modulator demonstrates biased antagonism of the follicle stimulating hormone receptor , 2011, Molecular and Cellular Endocrinology.

[82]  Robert I McLachlan,et al.  Hormonal regulation of sertoli cell micro-RNAs at spermiation. , 2011, Endocrinology.

[83]  G. Durand,et al.  Preferential β-arrestin signalling at low receptor density revealed by functional characterization of the human FSH receptor A189 V mutation , 2011, Molecular and Cellular Endocrinology.

[84]  Kwan Hee Kim,et al.  Activity of retinoic acid receptor-alpha is directly regulated at its protein kinase A sites in response to follicle-stimulating hormone signaling. , 2010, Endocrinology.

[85]  M. Hosoe,et al.  Biological and immunological characteristics of porcine follicle-stimulating hormone chemically modified with a polyethylene glycol derivative. , 2010, Veterinary journal.

[86]  S. Meachem,et al.  Hormonal regulation of male germ cell development. , 2010, The Journal of endocrinology.

[87]  W. Crowley,et al.  Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes. , 2010, The Journal of clinical endocrinology and metabolism.

[88]  A. Matsumoto,et al.  Serum LH correlates highly with intratesticular steroid levels in normal men. , 2010, Journal of andrology.

[89]  H. Guillou,et al.  FSH-stimulated PTEN activity accounts for the lack of FSH mitogenic effect in prepubertal rat Sertoli cells , 2010, Molecular and Cellular Endocrinology.

[90]  P. Bouloux,et al.  What is the optimal therapy for young males with hypogonadotropic hypogonadism? , 2009, Clinical endocrinology.

[91]  P. Dahlqvist,et al.  Testicular enlargement in a patient with a FSH-secreting pituitary adenoma , 2010, Endocrine.

[92]  M. Schumacher,et al.  Normal spermatogenesis in a man with mutant luteinizing hormone. , 2009, The New England journal of medicine.

[93]  U. Kaiser,et al.  The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism , 2009, Nature Reviews Endocrinology.

[94]  H. Guillou,et al.  Developmental regulation of p70 S6 kinase by a G protein-coupled receptor dynamically modelized in primary cells , 2009, Cellular and Molecular Life Sciences.

[95]  S. Bhasin,et al.  Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism. , 2009, Fertility and sterility.

[96]  P. Devroey,et al.  A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol , 2009, Human reproduction.

[97]  T. Plant,et al.  A selective monotropic elevation of FSH, but not that of LH, amplifies the proliferation and differentiation of spermatogonia in the adult rhesus monkey (Macaca mulatta). , 2009, Human reproduction.

[98]  P. Devroey,et al.  Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency. , 2009, Human reproduction update.

[99]  C. Foresta,et al.  Recombinant FSH in the treatment of oligozoospermia , 2009 .

[100]  David Handelsman,et al.  Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome. , 2009, The Journal of clinical endocrinology and metabolism.

[101]  Michael T. McManus,et al.  Sertoli cell Dicer is essential for spermatogenesis in mice. , 2009, Developmental biology.

[102]  H. Charlton,et al.  Effects of FSH on testicular mRNA transcript levels in the hypogonadal mouse , 2008, Journal of molecular endocrinology.

[103]  D. Modi,et al.  Poor ovarian response to gonadotrophin stimulation is associated with FSH receptor polymorphism. , 2009, Reproductive biomedicine online.

[104]  J. Auger,et al.  A new LH receptor splice mutation responsible for male hypogonadism with subnormal sperm production in the propositus, and infertility with regular cycles in an affected sister. , 2008, Human reproduction.

[105]  P. Baker,et al.  Spermatogenesis and sertoli cell activity in mice lacking sertoli cell receptors for follicle-stimulating hormone and androgen. , 2008, Endocrinology.

[106]  C. Holmes,et al.  Differing pharmacological activities of thiazolidinone analogs at the FSH receptor. , 2008, Biochemical and biophysical research communications.

[107]  K. Loveland,et al.  Pathways involved in testicular germ cell apoptosis in immature rats after FSH suppression. , 2008, The Journal of endocrinology.

[108]  A. Jablonka-Shariff,et al.  Single-chain human gonadotropin analogs induce follicle development in sheep. , 2008, The Journal of endocrinology.

[109]  Wei Yang,et al.  Testosterone upregulation of tissue type plasminogen activator expression in Sertoli cells , 2007, Endocrine.

[110]  J. Samarut,et al.  A point mutation in the activation function 2 domain of thyroid hormone receptor alpha1 expressed after CRE-mediated recombination partially recapitulates hypothyroidism. , 2007, Molecular endocrinology.

[111]  P. Froment,et al.  Inactivation of the IGF-I receptor gene in primary Sertoli cells highlights the autocrine effects of IGF-I. , 2007, The Journal of endocrinology.

[112]  M. Hirako,et al.  Responsiveness of rabbits to superovulation treatment by a single injection of follicle‐stimulating hormone with aluminum hydroxide gel , 2007, Molecular reproduction and development.

[113]  M. Hirako,et al.  Successful superovulation of cattle by a single administration of FSH in aluminum hydroxide gel. , 2007, Theriogenology.

[114]  C. Gauthier,et al.  A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation. , 2006, Molecular endocrinology.

[115]  E. Porcu,et al.  Effects of high doses of recombinant human follicle-stimulating hormone in the treatment of male factor infertility: results of a pilot study. , 2006, Fertility and sterility.

[116]  V. Piketty,et al.  G protein-coupled receptor kinase 2 and beta-arrestins are recruited to FSH receptor in stimulated rat primary Sertoli cells. , 2006, The Journal of endocrinology.

[117]  C. Holmes,et al.  Allosteric Activation of the Follicle-stimulating Hormone (FSH) Receptor by Selective, Nonpeptide Agonists* , 2006, Journal of Biological Chemistry.

[118]  Eric Reiter,et al.  GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling , 2006, Trends in Endocrinology & Metabolism.

[119]  L. O’Donnell,et al.  FSH regulates the formation of adherens junctions and ectoplasmic specialisations between rat Sertoli cells in vitro and in vivo. , 2006, Journal of Endocrinology.

[120]  Eric Reiter,et al.  GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. , 2006, Trends in endocrinology and metabolism: TEM.

[121]  P. Cooke,et al.  Regulation of Neonatal Sertoli Cell Development by Thyroid Hormone Receptor α11 , 2005 .

[122]  C. Foresta,et al.  Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study. , 2005, Fertility and sterility.

[123]  E. Nieschlag,et al.  Single-nucleotide polymorphisms in the promoter region influence the expression of the human follicle-stimulating hormone receptor. , 2005, Fertility and sterility.

[124]  L. Kiesel,et al.  Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation , 2005, Pharmacogenetics and genomics.

[125]  C. Timmers,et al.  Identification of substituted 6-amino-4-phenyltetrahydroquinoline derivatives: potent antagonists for the follicle-stimulating hormone receptor. , 2005, Journal of medicinal chemistry.

[126]  P. Cooke,et al.  Regulation of neonatal Sertoli cell development by thyroid hormone receptor alpha1. , 2005, Biology of reproduction.

[127]  M. Griswold,et al.  Follicle-stimulating hormone induced changes in gene expression of murine testis. , 2004, Molecular endocrinology.

[128]  C. Cheng,et al.  Sertoli-Sertoli and Sertoli-germ cell interactions and their significance in germ cell movement in the seminiferous epithelium during spermatogenesis. , 2004, Endocrine reviews.

[129]  P. Piomboni,et al.  Effect of follicle-stimulating hormone on sperm quality and pregnancy rate. , 2004, Asian journal of andrology.

[130]  S. Yeh,et al.  Infertility with defective spermatogenesis and hypotestosteronemia in male mice lacking the androgen receptor in Sertoli cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[131]  David Handelsman,et al.  Complete Sertoli cell proliferation induced by follicle-stimulating hormone (FSH) independently of luteinizing hormone activity: evidence from genetic models of isolated FSH action. , 2004, Endocrinology.

[132]  C. Holmes,et al.  Agonists of the follicle stimulating hormone receptor from an encoded thiazolidinone library. , 2004, Journal of combinatorial chemistry.

[133]  P. Carmeliet,et al.  A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[134]  Peixin Yang,et al.  Follicle Stimulating Hormone-Induced DNA Synthesis in the Granulosa Cells of Hamster Preantral Follicles Involves Activation of Cyclin-Dependent Kinase-4 Rather Than Cyclin D2 Synthesis1 , 2004, Biology of reproduction.

[135]  C. Niederberger,et al.  Recombinant human follicle-stimulating hormone as a pretreatment for idiopathic oligoasthenoteratozoospermic patients undergoing intracytoplasmic sperm injection. , 2003, Fertility and sterility.

[136]  J. Morrison,et al.  Thyroid hormone, retinoic acid, and testosterone suppress proliferation and induce markers of differentiation in cultured rat sertoli cells. , 2003, Endocrinology.

[137]  H. Burger,et al.  Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone. , 2003, Journal of andrology.

[138]  R. Sharpe,et al.  Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. , 2003, Reproduction.

[139]  L. C. Demirel,et al.  The effect of pure FSH administration in non-obstructive azoospermic men on testicular sperm retrieval. , 2003, European journal of obstetrics, gynecology, and reproductive biology.

[140]  M. Griswold,et al.  Oligonucleotide microarray analysis of gene expression in follicle-stimulating hormone-treated rat Sertoli cells. , 2002, Molecular endocrinology.

[141]  W. Crowley,et al.  Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. , 2002, The Journal of clinical endocrinology and metabolism.

[142]  M. Riera,et al.  Regulation of rat Sertoli cell function by FSH: possible role of phosphatidylinositol 3-kinase/protein kinase B pathway. , 2002, The Journal of endocrinology.

[143]  M. Sauer,et al.  Pharmacokinetics and pharmacodynamics of single-chain recombinant human follicle-stimulating hormone containing the human chorionic gonadotropin carboxyterminal peptide in the rhesus monkey. , 2002, Fertility and sterility.

[144]  P. Bouloux,et al.  Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism. , 2002, Fertility and sterility.

[145]  C. Foresta,et al.  Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility. , 2002, Fertility and sterility.

[146]  C. Cheng,et al.  Cell junction dynamics in the testis: Sertoli-germ cell interactions and male contraceptive development. , 2002, Physiological reviews.

[147]  P. Crépieux,et al.  G Protein-Coupled Receptor Kinases and Beta Arrestins Are Relocalized and Attenuate Cyclic 3′,5′-Adenosine Monophosphate Response to Follicle-Stimulating Hormone in Rat Primary Sertoli Cells1 , 2002, Biology of reproduction.

[148]  Pascale Crépieux,et al.  The ERK-dependent signalling is stage-specifically modulated by FSH, during primary Sertoli cell maturation , 2001, Oncogene.

[149]  C. Rao,et al.  Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. , 2001, Molecular endocrinology.

[150]  E. Nieschlag,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Ovarian Response to Follicle-Stimulating Hormone (FSH) Stimulation Depends on the FSH Receptor Genotype* , 2022 .

[151]  I. Huhtaniemi,et al.  The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction. , 2000, Endocrinology.

[152]  M. Plebani,et al.  FSH in the treatment of oligozoospermia , 2000, Molecular and Cellular Endocrinology.

[153]  R. Lilford,et al.  Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. , 1996, The Cochrane database of systematic reviews.

[154]  M. Kovo,et al.  Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization: the impact on sperm microstructure and fertilization potential. , 2000, Fertility and sterility.

[155]  A. Mcneilly,et al.  Dynamics of the Follicle-Stimulating Hormone (FSH)-Inhibin B Feedback Loop and Its Role in Regulating Spermatogenesis in the Adult Male Rhesus Monkey (Macaca mulatta) as Revealed by Unilateral Orchidectomy1. , 2000, Endocrinology.

[156]  A. Jablonka-Shariff,et al.  Genetic Fusion of an α-Subunit Gene to the Follicle-Stimulating Hormone and Chorionic Gonadotropin-β Subunit Genes: Production of a Bifunctional Protein , 1999 .

[157]  Z. Ben-Rafael,et al.  The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection. , 1999, Fertility and sterility.

[158]  C. Foresta,et al.  Evidence for a Stimulatory Role of Follicle-Stimulating Hormone on the Spermatogonial Population in Adult Males , 1999 .

[159]  E. Nieschlag,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Mutational Analysis of the Follicle-Stimulating Hormone (FSH) Receptor in Normal and Infertile Men: Identification and Characterization of Two Dis , 2022 .

[160]  A. Jablonka-Shariff,et al.  Genetic fusion of an alpha-subunit gene to the follicle-stimulating hormone and chorionic gonadotropin-beta subunit genes: production of a bifunctional protein. , 1999, Molecular endocrinology.

[161]  E. Nieschlag,et al.  Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. , 1998, Human reproduction.

[162]  B. Corcóstegui,et al.  Treatment of the male with follicle-stimulating hormone in intrauterine insemination with husband's spermatozoa: a randomized study. , 1998, Human reproduction.

[163]  E. Nieschlag,et al.  The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. , 1997, Endocrine reviews.

[164]  M. Muyan,et al.  Design of stable biologically active recombinant lutropin analogs , 1997, Nature Biotechnology.

[165]  K. Aittomäki,et al.  Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility , 1997, Nature Genetics.

[166]  M. Matzuk,et al.  Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility , 1997, Nature Genetics.

[167]  P. Grootenhuis,et al.  Expression of biologically active fusion genes encoding the common α subunit and either the CGβ or FSHβ subunits: role of a linker sequence , 1996, Molecular and Cellular Endocrinology.

[168]  E. Nieschlag,et al.  An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. , 1996, The Journal of clinical endocrinology and metabolism.

[169]  S. Meachem,et al.  Neonatal exposure of rats to recombinant follicle stimulating hormone increases adult Sertoli and spermatogenic cell numbers. , 1996, Biology of reproduction.

[170]  A. Hsueh,et al.  Expression of biologically active fusion genes encoding the common alpha subunit and either the CG beta or FSH beta subunits: role of a linker sequence. , 1996, Molecular and cellular endocrinology.

[171]  A. Hsueh,et al.  Biosynthesis of a biologically active single peptide chain containing the human common alpha and chorionic gonadotropin beta subunits in tandem. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[172]  J. Saez Leydig cells: endocrine, paracrine, and autocrine regulation. , 1994, Endocrine reviews.

[173]  B. Lunenfeld,et al.  Sperm quality of subfertile males before and after treatment with human follicle-stimulating hormone , 1994 .

[174]  J. Marx How p53 suppresses cell growth. , 1993, Science.

[175]  H. Delemarre-van de Waal,et al.  Pulsatile GnRH treatment in boys and girls with idiopathic hypogonadotrophic hypogonadism. , 1993, Human reproduction.

[176]  D. D. de Rooij,et al.  The effect of hypothyroidism on Sertoli cell proliferation and differentiation and hormone levels during testicular development in the rat. , 1992, Endocrinology.

[177]  E. Vicari,et al.  Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism--long-term follow-up. , 1992, International journal of andrology.

[178]  M. Conti,et al.  Properties and hormonal regulation of two structurally related cAMP phosphodiesterases from the rat Sertoli cell. , 1991, The Journal of biological chemistry.

[179]  J. Brown,et al.  Increased bioactivity of serum follicle-stimulating hormone, but not luteinizing hormone, following hemicastration in ram lambs. , 1990, Biology of reproduction.

[180]  J. Toppari,et al.  Cellular regulation of follicle-stimulating hormone (FSH) binding in rat seminiferous tubules. , 1990, Journal of andrology.

[181]  D. G. Rooij,et al.  Follicle-stimulating hormone stimulates spermatogenesis in the adult monkey , 1988 .

[182]  D. Vantman,et al.  A low sperm concentration does not preclude fertility in men with isolated hypogonadotropic hypogonadism after gonadotropin therapy. , 1988 .

[183]  E. Nieschlag,et al.  Treatment of severe oligospermia with human chorionic gonadotropin/human menopausal gonadotropin: a placebo-controlled, double blind trial. , 1987, The Journal of clinical endocrinology and metabolism.

[184]  I. Huhtaniemi,et al.  Follicle-stimulating hormone receptors appear earlier in the primate fetal testis than in the ovary. , 1987, The Journal of clinical endocrinology and metabolism.

[185]  B. Leverone,et al.  DNA sequence and regional assignment of the human follicle-stimulating hormone beta-subunit gene to the short arm of human chromosome 11. , 1987, DNA.

[186]  V. Kerlan,et al.  Leydig cell tumor with gynecomastia: further studies--the recovery after unilateral orchidectomy. , 1985, Journal of Clinical Endocrinology and Metabolism.

[187]  M. Conti,et al.  Hormonal regulation of 3',5'-adenosine monophosphate phosphodiesterases in cultured rat granulosa cells. , 1984, Endocrinology.

[188]  J. Massagué,et al.  The actions of insulin-like growth factors I and II on cultured Sertoli cells. , 1984, Endocrinology.

[189]  L. Johnson,et al.  Enhanced daily sperm production in the remaining testis of aged rats following hemicastration. , 1983, Journal of andrology.

[190]  M. Conti,et al.  Regulation of follicle-stimulating hormone and dibutyryl adenosine 3',5'-monophosphate of a phosphodiesterase isoenzyme of the Sertoli cell. , 1982, Endocrinology.

[191]  D. Tindall,et al.  Mechanisms for the testicular hypertrophy which follows hemicastration. , 1978, Endocrinology.

[192]  I. Fritz,et al.  Effects of follicle-stimulating hormone on cultures of sertoli cell preparations , 1975, Molecular and Cellular Endocrinology.

[193]  M. Griswold,et al.  Stimulation by follicle stimulating hormone and dibutyryl cyclic AMP of incorporation of 3H-thymidine into nuclear DNA of cultured Sertoli cell-enriched preparations from immature rats. , 1975, Current topics in molecular endocrinology.